Yes, TMS can be a reasonable option for depression later in life. The NeuroStar depression label, for example, is written for adult patients and states no upper age limit, and a 2025 meta-analysis of randomized trials in older adults found a benefit over control treatment. Age does change a few things: how the dose is set, which medical conditions need a closer look, how you will get to daily sessions, and, often, how the course is paid for.
This page walks through those differences so you and your family can judge whether TMS fits. It is general education, not a recommendation for any one person.
What the research shows in people over 60
Late-life depression has its own small but growing research base. The studies differ a lot in design, so it helps to see them side by side rather than as one headline number.
| Study | Design | Who | What it found |
|---|---|---|---|
| Meta-analysis, 2025 | 10 randomized trials pooled | Older adults with depression | Benefit over control on depression scores, response and remission; the effect showed up mainly in trials that used an intensity of at least 100% of resting motor threshold |
| Valiengo and colleagues, 2026 | Triple-blind, sham-controlled trial, 108 people | Age 60 and over, bilateral theta-burst | No significant difference at the main 6-week timepoint; active treatment pulled ahead by week 12 (response 52% vs 33%) |
| Deep TMS late-life report, 2024 | Open-label, manufacturer-affiliated, 247 people | Age 60 to 91 | 79.4% response and 60.3% remission after 30 sessions, using each person's "most rated" scale |
Read the last row with care. Those figures come from an open-label report with no sham group, so they cannot show how much of the improvement came from the treatment itself. The honest summary is that controlled trials support TMS in older adults, that in one recent trial the benefit did not appear until week 12, and that the size of the benefit varies. A Canadian guideline also notes that bilateral rTMS "may be considered first-line for late-life depression".
For how the overall depression evidence is built, see our plain-language guide to what TMS is.
Why age can change the dose
TMS is dosed for each person. Before treatment, the team finds your motor threshold, the lowest strength that makes your hand twitch, and then sets treatment strength as a percentage of it. The first-session mapping guide explains that visit step by step.
Age matters here because the magnetic field weakens with distance. With age-related brain shrinkage (atrophy), the surface of the brain can sit farther from the coil. In an early MRI study of 29 depressed adults, a longer distance from scalp to motor cortex went with a higher motor threshold, and the people who responded to TMS were significantly younger, although response did not track the distance itself. That study was small and is more than two decades old, but it explains why clinicians think about dose carefully in older patients.
The newer meta-analysis points the same way: benefit appeared mainly where intensity was at least 100% of motor threshold. One cleared accelerated system even builds in a depth correction between the motor area and the treatment target. If you want the technical details, the physician's guide to motor threshold and TMS dosing covers them.
What this means for you: ask how your team sets and adjusts intensity, and whether they consider brain imaging you may already have. You do not need a new scan just to have standard TMS, but existing imaging can be part of the conversation.
Fewer medicines, but not no screening
Many older adults already take several prescriptions. One practical appeal of TMS is that it is not a pill: it adds no new drug to your bloodstream, so it does not add the drug-interaction and side-effect burden another antidepressant might. Most people continue their usual medicines during a course; see keeping your medications during TMS.
A non-drug treatment still needs a careful medical review. FDA guidance asks for close monitoring of people with a history of seizure, stroke, head injury, other neurologic disease, or conditions that alter electrolyte balance. An international safety guideline adds metabolic problems such as low sodium or abnormal blood sugar, kidney or liver failure, and alcohol withdrawal to the list of factors that lower seizure threshold. Several of these are more common with age, which is why a full history matters.
Devices matter too. TMS is contraindicated with certain implants in or near the head, including deep brain stimulators, cochlear implants and vagus nerve stimulators. Pacemakers and implantable defibrillators carry a labeled warning in FDA guidance. Bring a list of every implant and device. Our page on implants, dental work and metal goes through the common ones.
The overall seizure risk is low. In a survey covering over 300,000 sessions, seizures were rare, and risk rose mainly with factors such as brain lesions and epilepsy. The full picture of everyday side effects is on TMS side effects.
Memory, thinking and the question of dementia
Families often worry about memory first. A review of 31 randomized trials of prefrontal rTMS found no reliable evidence of cognitive side effects. That is a meaningful difference from ECT, where memory effects are a known trade-off: a study of 347 patients at seven New York City-area facilities found adverse cognitive effects six months after the course. More on this in does TMS affect memory.
Depression in later life can also look like early memory decline, and the two can overlap. TMS for depression is not a treatment for dementia. A TMS-based system for Alzheimer's disease went before an FDA advisory panel in 2019, which found the pivotal study "did not demonstrate a clinically meaningful benefit", and that system is not FDA-authorized. If memory problems are part of the picture, a cognitive evaluation should come before or alongside any depression treatment.
Medicare is usually the payer
For most people over 65, Medicare's rules decide coverage. In Brooklyn, Medicare follows a local coverage policy (LCD L33398) that was revised for services from August 9, 2026. Under it, adults with confirmed major depression must meet one of several medication-history conditions, such as no clinically significant response to a trial of medicines from at least two different drug classes in the current episode, or intolerance shown by two trials from two classes. The policy also requires a trial of evidence-based psychotherapy without significant improvement, an order from a physician (or a non-physician practitioner where state scope of practice allows), and an FDA-cleared device. Treatment must be given under direct physician supervision, and maintenance TMS is not covered.
Medicare Advantage plans and supplemental plans may handle approval and cost-sharing differently. The physician's guide to Medicare coverage for TMS in New York explains the policy in detail, and does insurance cover TMS covers the wider picture.
Getting there five days a week
A standard course is daily on weekdays. One cleared schedule is 5 days a week for 6 weeks, then a 3-week taper, for 36 sessions in all. Expert consensus tells patients that 20 to 30 sessions over about 6 weeks will very likely be needed. Session length depends on the protocol: a standard 10 Hz session can be as short as about 19 minutes, while a theta-burst session takes about 3 minutes of stimulation.
For many older adults, the stimulation is the easy part and the trip is the hard part. Plan for:
- Transport you can count on. TMS involves no sedation, so many people travel on their own, but a ride from family, a car service or paratransit can make the routine sustainable, especially in winter.
- Mobility and comfort. Ask whether the treatment chair and building are accessible, and whether you can take breaks if sitting still is hard.
- Hearing. Earplugs are required during treatment. If you use hearing aids, they come out for sessions, because removable metal or electronic objects near the coil should be removed.
- A support person. Someone who notices changes in mood, sleep or confusion is valuable, and supporting a loved one through TMS is written for them.
Our guide to fitting daily sessions into a Brooklyn week has practical travel planning.
When TMS is not the right first step
TMS is not the answer to every late-life depression. Expert consensus says people with psychotic symptoms or acute suicidal thoughts should be considered for treatments with established efficacy in those situations, such as ECT. In a 2014 meta-analysis of nine head-to-head trials, ECT's advantage over high-frequency rTMS was clearest in psychotic depression.
Other situations call for a different starting point:
- A first episode of depression that starts late in life, especially with confusion or physical symptoms, deserves a medical workup first. Thyroid problems, medication effects, sleep apnea and early neurologic disease can all look like depression.
- If only one medicine has been tried, or it was never given at a full dose for long enough, adjusting treatment may make more sense. See what treatment-resistant depression really means.
- Grief, isolation and big life changes often drive late-life low mood. Therapy and social reconnection may matter as much as any device.
If you are thinking about suicide or are in crisis, call or text 988 (the 988 Suicide & Crisis Lifeline) or go to the nearest emergency room.
Questions to bring to the consultation
- How will you set my dose, and will you account for age-related changes?
- Which of my conditions, medicines or implants need extra review before I start?
- What schedule will I need, and how long does each visit take?
- Will my Medicare or Medicare Advantage plan cover this, and what does approval require?
- How will you measure whether it is working, and what happens if it does not?
Our TMS consultation guide explains what to bring. Older readers may also find our earlier article on treating depression in the elderly useful, and the TMS guide collects every topic in one place. When you are ready to talk about your own situation, start with TMS therapy.
Sources
- Repetitive transcranial magnetic stimulation for late-life depression: A systematic review and meta-analysis of randomized controlled trials. Journal of International Medical Research, 2025. europepmc.org
- Bilateral Theta-Burst Stimulation of Dorsolateral Prefrontal Cortex Regions for Late-Life Depression: A Randomized, Sham-Controlled Clinical Trial. American Journal of Psychiatry, 2026. pubmed.ncbi.nlm.nih.gov
- Never Too Late: Safety and Efficacy of Deep TMS for Late-Life Depression. Journal of Clinical Medicine, 2024. pubmed.ncbi.nlm.nih.gov
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults. Canadian Journal of Psychiatry, 2024. pmc.ncbi.nlm.nih.gov
- K220177 510(k) Summary - Magnus Neuromodulation System with SAINT Technology. U.S. Food and Drug Administration, 2022. accessdata.fda.gov
- How coil-cortex distance relates to age, motor threshold, and antidepressant response to repetitive transcranial magnetic stimulation. Journal of Neuropsychiatry and Clinical Neurosciences, 2000. pubmed.ncbi.nlm.nih.gov
- Class II Special Controls Guidance Document: Repetitive Transcranial Magnetic Stimulation (rTMS) Systems. U.S. Food and Drug Administration, 2011. fda.gov
- Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines. Clinical Neurophysiology, 2021. europepmc.org
- Seizures from transcranial magnetic stimulation 2012-2016: Results of a survey of active laboratories and clinics. Clinical Neurophysiology, 2019. europepmc.org
- Brief Summary of the Neurological Devices Panel Meeting - March 21, 2019: neuroAD Therapy System. U.S. Food and Drug Administration, 2019. fda.gov
- Transcranial Magnetic Stimulation, LCD L33398 (version 40). Centers for Medicare & Medicaid Services, 2026. cms.gov
- K231926 510(k) Summary - NeuroStar Advanced Therapy System. U.S. Food and Drug Administration, 2024. accessdata.fda.gov
- Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression. Journal of Clinical Psychiatry, 2018. pmc.ncbi.nlm.nih.gov
- K173620 510(k) Summary - MagVita TMS Therapy System w/Theta Burst Stimulation. U.S. Food and Drug Administration, 2018. accessdata.fda.gov
- Repetitive transcranial magnetic stimulation versus electroconvulsive therapy for major depression: a systematic review and meta-analysis. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2014. pubmed.ncbi.nlm.nih.gov
- 510(k) K160703 - NeuroStar TMS Therapy System. U.S. Food and Drug Administration, 2016. accessdata.fda.gov
- The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology, 2007. pubmed.ncbi.nlm.nih.gov
FAQs
Is there an age limit for TMS?
The NeuroStar depression label, for example, describes adult patients and does not state an upper age limit; other devices' labels may differ. Your psychiatrist decides based on your health, not your birthday.
Is TMS safer than adding another antidepressant for an older person?
It avoids adding a new drug, which helps people who already take many medicines. It has its own risks, mainly scalp discomfort, headache and a rare seizure risk, so the right choice depends on your history. See TMS or another antidepressant.
Can someone with mild memory problems have TMS?
Often yes, if depression is the problem being treated. Trials have not found reliable cognitive side effects from prefrontal TMS, but memory complaints should be evaluated on their own, since TMS is not a dementia treatment.
Can I keep my hearing aids in during sessions?
No. Removable metal or electronic items near the coil are taken off, and you wear earplugs during treatment. Bring a way to communicate with staff if hearing is difficult without your aids.
Does Medicare pay for maintenance TMS?
No. The Medicare policy that applies in Brooklyn states that maintenance TMS is not covered. A repeat course after relapse is a separate question to raise with your psychiatrist.
